OBJECTIVES: To evaluate the relationship between serial cardiac troponin T (cTnT) levels with infarct size and left ventricular ejection fraction by gated single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients with acute myocardial infarction (AMI). BACKGROUND: Current guidelines recommend the use of cTnT as the biomarker of choice for the diagnosis of AMI. Data relating cTnT to SPECT-MPI in patients with AMI are limited. METHODS: A subset of patients with their first AMI participating in a community-based cohort of AMI in Olmsted County, Minnesota, were prospectively studied. Serial cTnT levels were evaluated at presentation, <12 h and 1, 2, and 3 days after onset of pain. Peak cTnT was defined as the maximum cTnT value. RESULTS: A total of 121 patients (age, 61 ± 13 years; 31% women) with AMI underwent gated SPECT-MPI at a median (25th percentile, 75th percentile) of 10 (5, 15) days post-AMI. The type of infarct was non-ST-segment elevation myocardial infarction in 61%, and 13% were anterior in location. The median infarct size was 1% (0%, 11%) and the median gated left ventricular ejection fraction was 54% (47%, 60%). Fifty-nine patients (49% of the population) had no measurable infarction by SPECT-MPI. Independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT, but not at presentation or <12 h. In receiver-operator characteristic analysis, the area under the curve was highest at day 3. Receiver-operator characteristic analysis demonstrated a cutoff of 1.5 ng/ml for peak cTnT for the detection of measurable infarct size. CONCLUSIONS: In a community-based cohort of patients with their first AMI, independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT. In contrast, cTnT level at presentation and <12 h was not an independent predictor of myocardial infarction size as assessed by SPECT-MPI. Receiver-operator characteristic analysis demonstrated a cutoff value peak cTnT of 1.5 ng/ml for the detection of measurable infarct.
OBJECTIVES: To evaluate the relationship between serial cardiac troponin T (cTnT) levels with infarct size and left ventricular ejection fraction by gated single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in patients with acute myocardial infarction (AMI). BACKGROUND: Current guidelines recommend the use of cTnT as the biomarker of choice for the diagnosis of AMI. Data relating cTnT to SPECT-MPI in patients with AMI are limited. METHODS: A subset of patients with their first AMI participating in a community-based cohort of AMI in Olmsted County, Minnesota, were prospectively studied. Serial cTnT levels were evaluated at presentation, <12 h and 1, 2, and 3 days after onset of pain. Peak cTnT was defined as the maximum cTnT value. RESULTS: A total of 121 patients (age, 61 ± 13 years; 31% women) with AMI underwent gated SPECT-MPI at a median (25th percentile, 75th percentile) of 10 (5, 15) days post-AMI. The type of infarct was non-ST-segment elevation myocardial infarction in 61%, and 13% were anterior in location. The median infarct size was 1% (0%, 11%) and the median gated left ventricular ejection fraction was 54% (47%, 60%). Fifty-nine patients (49% of the population) had no measurable infarction by SPECT-MPI. Independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT, but not at presentation or <12 h. In receiver-operator characteristic analysis, the area under the curve was highest at day 3. Receiver-operator characteristic analysis demonstrated a cutoff of 1.5 ng/ml for peak cTnT for the detection of measurable infarct size. CONCLUSIONS: In a community-based cohort of patients with their first AMI, independent predictors of measurable SPECT-MPI infarct size included cTnT at days 1, 2, and 3 and peak cTnT. In contrast, cTnT level at presentation and <12 h was not an independent predictor of myocardial infarction size as assessed by SPECT-MPI. Receiver-operator characteristic analysis demonstrated a cutoff value peak cTnT of 1.5 ng/ml for the detection of measurable infarct.
Authors: Véronique L Roger; Jill M Killian; Susan A Weston; Allan S Jaffe; Jan Kors; Paula J Santrach; Hugh Tunstall-Pedoe; Steven J Jacobsen Journal: Circulation Date: 2006-08-14 Impact factor: 29.690
Authors: B R Chaitman; M G Bourassa; K Davis; W J Rogers; D H Tyras; R Berger; J W Kennedy; L Fisher; M P Judkins; M B Mock; T Killip Journal: Circulation Date: 1981-08 Impact factor: 29.690
Authors: D B Hackel; K A Reimer; R E Ideker; E M Mikat; T D Hartwell; C B Parker; E B Braunwald; M Buja; H K Gold; A S Jaffe Journal: Circulation Date: 1984-11 Impact factor: 29.690
Authors: Erik Hedström; Karin Aström-Olsson; Hans Ohlin; Fredrik Frogner; Marcus Carlsson; Therese Billgren; Stefan Jovinge; Peter Cain; Galen S Wagner; Håkan Arheden Journal: Scand Cardiovasc J Date: 2007-01 Impact factor: 1.589
Authors: Meg Fraser; Arianne Clare C Agdamag; Valmiki R Maharaj; Melinda Mutschler; Victoria Charpentier; Mohammed Chowdhury; Tamas Alexy Journal: Biology (Basel) Date: 2022-03-28
Authors: Eva Steinacher; Felix Hofer; Niema Kazem; Andreas Hammer; Lorenz Koller; Irene Lang; Christian Hengstenberg; Alexander Niessner; Patrick Sulzgruber Journal: J Pers Med Date: 2022-07-22
Authors: Valentina Parisi; Serena Cabaro; Vittoria D'Esposito; Laura Petraglia; Maddalena Conte; Pasquale Campana; Gerardo Gerundo; Marianna Abitabile; Andrea Tuccillo; Maria Accadia; Giuseppe Comentale; Emanuele Pilato; Mario Sansone; Dario Leosco; Pietro Formisano Journal: Front Physiol Date: 2020-10-15 Impact factor: 4.566